Health care policy researcher Nancy Keating discusses two new studies that suggest the short-lived experiment was more ...

An experimental gene therapy for a rare form of genetic deafness has successfully restored hearing in children and adults, ...

Nettey was early in his MD-PhD training in immunology in the Harvard-MIT Program in Health Sciences and Technology (HST) when ...

Stuart Orkin, the Harvard Medical School David G. Nathan Distinguished Professor of Pediatrics at Dana-Farber Cancer ...

The work demonstrates the power of ancient DNA to illuminate human biology and medicine in addition to history. A massive ...

Two students in the Harvard/MIT MD-PhD program have been awarded the prestigious Paul and Daisy Soros Fellowships for New ...

Three Harvard Medical School students have been awarded the prestigious Paul and Daisy Soros Fellowships for New Americans, a ...

Talaspayeva is adding her own advancements to the field. Her master’s capstone project focuses on anti-VEGF treatment, a ...

The future of federally funded research at Harvard Medical School — supported by taxpayers and done in service to humanity — remains uncertain. Learn more. A new analysis led by researchers at Harvard ...

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets. He has studied how national ...

A protein called STUB1 weakens the cancer-killing power of immune T cells by blocking key signals they need to attack tumors. Disabling STUB1 in lab experiments strengthened T cells’ response to the ...

Study shows for the first time that lithium plays an essential role in normal brain function and can confer resistance to brain aging and Alzheimer’s disease. Scientists discovered that lithium is ...